Get started
ThomasTuanNguyen

Short NRSN - IPO Lockup Expires 6/7/2022

Short
NeuroSense Therapeutics Ltd. (NASDAQ:NRSN)  
ThomasTuanNguyen  
NASDAQ:NRSN   NeuroSense Therapeutics Ltd.
Trend Analysis
2
0
trendanalysis
Little to no news, increasing net revenue losses year-over-year and tremendously spike in short-interest, now would be a good time to short.

Between the earnings call and expiring IPO lockup, NRSN leaning towards a dramatic drop.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.